Cancer Research is a popular and profitable industry that has come a long way over the years. Even though cancer itself is still prevalent in today’s society, the future is looking much more brighter thanks to some innovative medications and the ingenuity of Clay Siegall. Clay Siegall is widely known as a doctor, scientist, guest speaker, and philanthropist. He is the current CEO and President as well as Founder of Biotech Company Seattle Genetics. This guy has a strong backing of support within the industry and he’s well respected among his peers thanks to his brilliance. The way he implements his thoughts, ideas, and actions into play should be admired as he’s laid the blueprint to success in this field.
The good doctor has a heart of gold and spends most of his time helping others. Having such compassion is another reason that he is known as a philanthropist. Dr. Siegall has taken this organization straight to the top as Seattle Genetics is now a major player in the fight against cancer. Over the past few years Forbes had it on it’s list of the fastest growing companies in America. The Bothell, Washington based organization was visited by Vice president Joe Bidden early last year in part by it’s great success and news headlines. This “one-two punch” of excellence is giving cancer all it can handle and the great thing about it that there are many more drugs in the pipeline being tested for future reference. The company’s flagship drug (ADCETRIS) is setting new trends from it’s effectiveness. It has made hundreds of millions of dollars in the U.S. and Canada alone.
Dr. Clay Siegall has also helped to raise $1.2 Billion (via) private and public funding which go to future projects while helping to sustain the business. As you can see, the outlook in cancer research is much more positive and the world owes much of the credit to Dr. Clay Siegall.